Canada Life’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,881
| Closed | -$92K | – | 2614 |
|
|
2021
Q1 | $92K | Hold |
3,881
| – | – | ﹤0.01% | 2125 |
|
|
2020
Q4 | $56K | Hold |
3,881
| – | – | ﹤0.01% | 2245 |
|
|
2020
Q3 | $55K | Hold |
3,881
| – | – | ﹤0.01% | 2159 |
|
|
2020
Q2 | $57K | Hold |
3,881
| – | – | ﹤0.01% | 2191 |
|
|
2020
Q1 | $16K | Hold |
3,881
| – | – | ﹤0.01% | 2434 |
|
|
2019
Q4 | $18K | Buy |
+3,881
| New | +$21.4K | ﹤0.01% | 2519 |
|
|
2019
Q3 | – | Sell |
-7,315
| Closed | -$47K | – | 2602 |
|
|
2019
Q2 | $47K | Hold |
7,315
| – | – | ﹤0.01% | 2457 |
|
|
2019
Q1 | $52K | Hold |
7,315
| – | – | ﹤0.01% | 2250 |
|
|
2018
Q4 | $34K | Hold |
7,315
| – | – | ﹤0.01% | 2477 |
|
|
2018
Q3 | $54K | Hold |
7,315
| – | – | ﹤0.01% | 2377 |
|
|
2018
Q2 | $47K | Hold |
7,315
| – | – | ﹤0.01% | 2415 |
|
|
2018
Q1 | $40K | Hold |
7,315
| – | – | ﹤0.01% | 2413 |
|
|
2017
Q4 | $30K | Hold |
7,315
| – | – | ﹤0.01% | 2451 |
|
|
2017
Q3 | $68K | Buy |
7,315
+5,315
| +266% | +$55.2K | ﹤0.01% | 2257 |
|
|
2017
Q2 | $24K | Hold |
2,000
| – | – | ﹤0.01% | 2477 |
|
|
2017
Q1 | $26K | Hold |
2,000
| – | – | ﹤0.01% | 2434 |
|
|
2016
Q4 | $25K | Sell |
2,000
-6,900
| -78% | -$81.9K | ﹤0.01% | 2465 |
|
|
2016
Q3 | $105K | Hold |
8,900
| – | – | ﹤0.01% | 2118 |
|
|
2016
Q2 | $77K | Hold |
8,900
| – | – | ﹤0.01% | 2199 |
|
|
2016
Q1 | $47K | Hold |
8,900
| – | – | ﹤0.01% | 2160 |
|
|
2015
Q4 | $69K | Hold |
8,900
| – | – | ﹤0.01% | 2001 |
|
|
2015
Q3 | $70K | Hold |
8,900
| – | – | ﹤0.01% | 1934 |
|
|
2015
Q2 | $80K | Hold |
8,900
| – | – | ﹤0.01% | 2008 |
|
|
2015
Q1 | $115K | Hold |
8,900
| – | – | ﹤0.01% | 1716 |
|
|
2014
Q4 | $121K | Hold |
8,900
| – | – | ﹤0.01% | 1620 |
|
|
2014
Q3 | $80K | Hold |
8,900
| – | – | ﹤0.01% | 1847 |
|
|
2014
Q2 | $120K | Buy |
+8,900
| New | +$92.9K | ﹤0.01% | 1453 |
|
Canada Life's GNMK Position: Q2 2021 in Review
Canada Life sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 3,881 shares — an estimated $92K sold.
Canada Life first reported a position in GNMK in Q2 2014 and held it in 27 quarters. The position peaked at $121K in Q4 2014. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Canada Life reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Canada Life sold 3,881 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $92K.
- Canada Life first reported a position in GenMark Diagnostics, Inc in Q2 2014 and held it in 27 quarters.
- Canada Life's GenMark Diagnostics, Inc position peaked at $121K in Q4 2014.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Canada Life's 13F filing for Q2 2021, filed 11 Aug 2021.